Aigen Investment Management »

Summit Therapeutics shares owned by Aigen Investment Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Aigen Investment Management from 13F filings

Historical chart of Aigen Investment Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Aigen Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Aigen Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $357k 25k 14.57
2024-09-30 $306k 14k 21.90